TPTGF News Alert Topotarget A/S Copen (TPTGF) 0.6806 10/01/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Topotarget A/S Copen (TPTGF) 0.6806 $TPTGF

Therapeutic Report for Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
M2 - Tue Aug 06, 5:00AM CDT
Research and Markets (http://www.researchandmarkets.com/research/5sqnpw/acute_lymphocytic) has announced the addition of the "Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H2 2012" report to their offering. This report provides an overview of the acute lymphocytic leukemia therapeutic pipeline. It provides information on the therapeutic development for acute lymphocytic leukemia complete with latest updates, and special features on late-stage and discontinued projects. The document is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Scope - A snapshot of the global therapeutic scenario for acute lymphocytic leukemia. - A review of the acute lymphocytic leukemia products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the acute lymphocytic leukemia pipeline on the basis of route of administration and molecule type. - Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress. Reasons to buy - Identify and understand important and diverse types of therapeutics under development for acute lymphocytic leukemia. - Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage. - Plan mergers and acquisitions effectively by identifying players with the most promising pipeline. - Devise corrective measures for pipeline projects by understanding acute lymphocytic leukemia pipeline depth and focus of acute lymphocytic leukemia therapeutics. Key Topics Covered: List of Tables List of Figures Introduction Report Coverage Acute Lymphocytic Leukemia Overview Therapeutics Development An Overview of Pipeline Products for Acute Lymphocytic Leukemia Companies Involved in Acute Lymphocytic Leukemia Therapeutics Development Drug Profiles Featured News & Press Releases Appendix Companies Mentioned (40) Including: - 4SC AG - Ariad Pharmaceuticals - Bio-Path Holdings - Bristol-Myers Squibb Company - CanBas Co - Exelixis - F. Hoffmann-La Roche - Genzyme Corporation - Hana Biosciences - Incyte Corporation - Jazz Pharmaceuticals - KaloBios Pharmaceuticals - Lentigen Corporation - Millennium Pharmaceuticals - MorphoSys AG - Mundipharma International - Novartis AG - Onconova Therapeutics - Oryzon - Pfizer - Proacta - Sigma-Tau Pharmaceuticals - SuperGen - SymbioTec GmbH - Threshold Pharmaceuticals - TopoTarget A/S - Tragara Pharmaceuticals For more information visit http://www.researchandmarkets.com/research/5s...ymphocytic

T-Cell Lymphomas - Pipeline Review, H2 2012
M2 - Fri Aug 02, 6:40AM CDT
Research and Markets (http://www.researchandmarkets.com/research/pz4gz2/tcell_lymphomas) has announced the addition of the "T-Cell Lymphomas - Pipeline Review, H2 2012" report to their offering. This research provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for T-Cell lymphomas, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for T-Cell lymphomas. The document is built using data and information proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Scope - A snapshot of the global therapeutic scenario for T-Cell lymphomas. - A review of the T-Cell lymphomas products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the T-Cell lymphomas pipeline on the basis of route of administration and molecule type. - Key discontinued pipeline projects. - Latest news and deals relating to the products. Reasons to buy - Identify and understand important and diverse types of therapeutics under development for T-Cell lymphomas. - Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage. - Plan mergers and acquisitions effectively by identifying players of the most promising pipeline. - Devise corrective measures for pipeline projects by understanding T-Cell lymphomas pipeline depth and focus of Indication therapeutics. Key Topics Covered: List of Tables List of Figures Introduction Report Coverage T-Cell Lymphomas Overview Therapeutics Development An Overview of Pipeline Products for T-Cell Lymphomas Companies Involved in T-Cell Lymphomas Therapeutics Development T-Cell Lymphomas - Therapeutics Assessment Drug Profiles Featured News & Press Releases Appendix Companies Mentioned: - Abbott Laboratories - Allos Therapeutics, Inc - Amgen Inc - Celgene Corporation - Cephalon - Chipscreen Biosciences Ltd - Eisai Co - Emergent BioSolutions Inc - Incyte Corporation - Kyowa Hakko Kirin Co - Millennium Pharmaceuticals - Mundipharma International Limited - Nerviano Medical Sciences - PharmaMar - Pharmacyclics, Inc - Sareum Holdings - Seattle Genetics, Inc - TopoTarget A/S - Xencor, Inc - ZIOPHARM Oncology For more information visit http://www.researchandmarkets.com/research/pz..._lymphomas

Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2013
M2 - Fri Apr 12, 5:22AM CDT
Research and Markets has announced the addition of the "Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2013" report to their offering. 'Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Peripheral T-Cell Lymphomas (PTCL), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Peripheral T-Cell Lymphomas (PTCL). Scope - A snapshot of the global therapeutic scenario for Peripheral T-Cell Lymphomas (PTCL). - A review of the Peripheral T-Cell Lymphomas (PTCL) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects o

Soft Tissue Sarcoma - Pipeline Review, H2 2012
M2 - Mon Jan 07, 8:07AM CST
Research and Markets (http://www.researchandmarkets.com/research/f4g9mh/soft_tissue) has announced the addition of Global Markets Direct's new report "Soft Tissue Sarcoma - Pipeline Review, H2 2012" to their offering. 'Soft Tissue Sarcoma - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Soft Tissue Sarcoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Soft Tissue Sarcoma. Soft Tissue Sarcoma - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Reasons to buy - Identify and understand important and di




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Chicago Auto Show: Run & Explore Indoors This February

Updated Category News Views 59

Nobody’s thinking about running laps when they walk into a colossal auto show, but the Chicago Auto Show isn't letting the pedal ease off the gas. Swing by on February 14, folks, for something not typically seen on the floors of McCormick Place. Run participants have got one hour to log as many miles as they can on the 2.4-mile loop right inside the show. Why a Running...

Continue Reading
Mars Moves on Cash Tender Offers for Seniors' Notes

Updated Category News Views 104

A Strategic Financial Maneuver or a Casual Gambit? Okay, what’s Mars up to now, you ask? Here we go with this. The behemoth behind some of your favorite snacks and pet indulgences is making waves—not with candy, but with cash. Mars, Incorporated is rolling out tender offers to buy back a substantial chunk of its Senior Notes for $2 billion in cold, hard cash. When a...

Continue Reading
VIO Med Spa’s Black Friday Event: Aesthetic Savings

Updated Category News Views 123

Kicking Off the Holiday Season with a Glow Just when you think the holiday hustle can't get busier, VIO Med Spa is opening the gates of rejuvenation just in time to add yourself to that epic list. Starting November 16, VIO launches its Black Friday extravaganza—a deal-laden kick-off that means smooth skin and sharper looks are up for grabs. Member Benefits and Public...

Continue Reading
MoneyGram and Solflare Boost Crypto Cash-Out Options

Updated Category News Views 116

Crypto Meets Cash: A New Partnership in Money Movement Here's something to chew over your morning joe: MoneyGram's stepping up its game in the crypto world. They're pairing up with Solflare to let folks convert their USDC into hard cash across 170 countries and territories—no fees until New Year's Eve. It's like crypto's getting a passport to the physical world and not...

Continue Reading
Daymond John's Four-Center Bet on Longevity Game

Updated Category News Views 66

A Shark's Dive into Longevity Here you go—Daymond John, the face of FUBU and a household name from Shark Tank, is not just talking about living longer; he's putting his wallet where his words are. John is jumping into the longevity game with both feet, joining Ultimate Longevity Center's (ULC) latest venture. We're talking about four new centers across California,...

Continue Reading
Scientific Games Joins NCPG’s 2026 Campaign Again

Updated Category News Views 142

Scientific Games Backs Responsible Gaming Again It's another year, and here's Scientific Games once more, guns blazing for a cause that's needed more than a few times over—responsible gambling. Those folks got their hearts in the right place, joining the National Council on Problem Gambling's 2026 Gift Responsibly campaign. Ninth time running, no less! It's like...

Continue Reading
Sinch Appoints Jonas Dahlberg as New CEO: A Strategic Move

Updated Category News Views 47

A Change at the Helm: Dahlberg Takes Charge Here we go, folks—Sinch, that global powerhouse in customer communications, just got itself a new captain. Jonas Dahlberg is now officially the CEO, after warming the acting CEO seat since June. This ain't your ordinary office shuffle. It's a calculated chess move in the high-stakes tech world. Dahlberg's Path to the Top This...

Continue Reading
Trades Workforce Shortage Costs Wallop U.S. Economy

Updated Category News Views 113

The Forgotten Backbone of America Don't sleep on this: America's got itself a trade worker crisis, and it's not just a numerical hiccup. We’re down nearly 1.9 million skilled trades workers, and that's a gut punch to the economy—a hefty $1.2 billion a day in GDP loss. These are the folks who keep the wheels greased, the lights on, and the goods flowing. Without them,...

Continue Reading
Alliance for Women in Media Champions Change in 2026

Updated Category News Views 76

A Celebration of Trailblazing Women in Media If there's one thing I've learned about strong leadership, it's that you can't fake authenticity. Today, we're tipping our hats to some genuine trailblazers. The Alliance for Women in Media (AWM) held its annual Gracies Leadership Awards, celebrating the achievements and vision of seven remarkable women. Honoring the...

Continue Reading
Webull Faces FINRA Fine and Legal Battle Ahead

Updated Category News Views 100

Webull's Compliance Headache Webull’s been knocked around again. This time, the Financial Industry Regulatory Authority (FINRA) slapped it with a hefty $4.2 million fine. Talk about a hit to the wallet! It all boils down to them failing to roll out some basic anti-money laundering (AML) and other crucial compliance programs. This is no small oversight, and it's got...

Continue Reading

Top 5 Most Recently Viewed Articles

South32 Secures Key Environmental Approval for Worsley Mine

Updated Category News Views 283

South32's Worsley Mine Project Receives Environmental Approval Perth-based South32 (ASX / LSE / JSE: S32; OTC: SOUHY), an Australian leader in mining and metals, has recently obtained essential state environmental approval for its Worsley Mine Development Project. This significant milestone brings the company a step closer to accessing necessary bauxite resources, vital...

Continue Reading
Tesla's Future Beyond EVs: The Rise of AI, Robotics, and Robotaxis

Updated Category News Views 471

Tesla's Future Beyond EVs: The Rise of AI, Robotics, and Robotaxis Tesla Inc. (NASDAQ:TSLA) is trading near $418.02, showcasing a remarkable market cap of $1.31 trillion and a P/E ratio of 279.5. This impressive valuation not only underscores the innovation premium associated with Tesla but also reflects the intense valuation pressures it faces. The company has...

Continue Reading
Smartkem Showcases Innovative Display Technology at TechBlick

Updated Category News Views 44

Smartkem Set to Exhibit at TechBlick: A Spotlight on Future Electronics Smartkem, Inc. (NASDAQ: SMTK), a leader in transformative display technologies, is gearing up to showcase its innovative offerings at an upcoming global conference centered on electronics. This event, known as TechBlick: The Future of Electronics Reshaped, will take place at the Estrel Berlin Hotel...

Continue Reading
American Rebel Light Beer: Expanding Horizons in Iowa

Updated Category News Views 170

American Rebel Light Beer Expands Distribution in Iowa American Rebel Light to be served at Knoxville Raceway and the Dingus Lounge Nashville, TN — American Rebel Holdings, Inc. (NASDAQ: AREB) proudly announces its strategic expansion into Iowa through a partnership with Mahaska Bottling Company. This important move marks a significant milestone in the Company's broader...

Continue Reading
Boys & Girls Clubs Ignite Hope with Woodlands Impact Center

Updated Category News Views 195

Boys & Girls Clubs of the Northwest Suburbs Renovate New Facility The Woodlands Impact Center is poised to play a vital role in empowering local youth by providing essential services and programs. This facility aims to support 550 students, offering after-school, summer, and daytime activities that will enrich their educational and social experiences. A Transformative...

Continue Reading